Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKingfisher Regulatory News (KGF)

Share Price Information for Kingfisher (KGF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 255.80
Bid: 255.60
Ask: 255.70
Change: -7.40 (-2.81%)
Spread: 0.10 (0.039%)
Open: 262.30
High: 262.90
Low: 255.30
Prev. Close: 263.20
KGF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

6 Mar 2023 07:00

RNS Number : 9067R
Kingfisher PLC
06 March 2023
 

KINGFISHER PLC

Transaction in own shares

 

6 March 2023: Kingfisher plc, ISIN: GB0033195214 (the "Company", "Kingfisher") announces that on 3 March 2023 it purchased for cancellation the following number of ordinary shares of 15 5/7 pence each from BNP Paribas Exane, Intermediary Code: 969500UP76J52A9OXU27 ("BNP Paribas Exane") as part of its £300 million capital return programme announced on 23 May 2022 (the "Programme"). All shares were purchased by Kingfisher from BNP Paribas Exane as an "on-exchange" transaction in accordance with the rules of the London Stock Exchange.

Date of purchase:

3 March 2023

Total number of shares purchased:

39,700

Volume Weighted Average price paid per share:

GBp 283.2405

Highest price paid per share:

GBp 285.7000

Lowest price paid per share:

GBp 280.9000

 

To date, Kingfisher has purchased 19,040,491 ordinary shares in aggregate for cancellation from BNP Paribas Exane in connection with the third tranche of the Programme. Kingfisher also previously purchased 30,583,514 ordinary shares in aggregate for cancellation from Goldman Sachs International and 31,306,331 ordinary shares in aggregate for cancellation from Credit Suisse International in connection with its execution of the first and second tranches, respectively, of the Programme.

A schedule of individual trades carried out by BNP Paribas Exane as principal in connection with the above purchases is set out below.

Schedule of Purchases - Aggregate Information

Trading Venue

Number of Shares

Volume Weighted Average Price paid per share

XLON

39,586

GBp 283.2366

BATE

114

GBp 284.6000

 

Schedule of Purchases - Individual Transactions

Price GBp

Time of each trade on 3 March 2023 (UTC)

Trading venue

Quantity

Transaction Reference Number

281.7

08:09:02

XLON

1,880

00337833204EXPA1

280.9

08:17:32

XLON

2,336

00337834675EXPA1

281.9

08:49:34

XLON

2,353

00337838983EXPA1

282.3

09:10:55

XLON

2,242

00337842846EXPA1

283.4

10:07:15

XLON

569

00337851406EXPA1

283.4

10:07:15

XLON

1,355

00337851407EXPA1

283.3

10:14:58

XLON

2,049

00337852508EXPA1

283.0

10:28:37

XLON

2,064

00337854201EXPA1

282.1

11:19:34

XLON

136

00337863272EXPA1

282.1

11:19:34

XLON

1,834

00337863273EXPA1

282.0

11:33:30

XLON

8

00337866390EXPA1

282.0

11:33:30

XLON

89

00337866391EXPA1

282.0

11:33:30

XLON

1,368

00337866392EXPA1

282.7

12:03:28

XLON

996

00337871752EXPA1

282.1

12:28:03

XLON

2,347

00337874582EXPA1

282.7

13:16:05

XLON

974

00337880631EXPA1

282.7

13:16:05

XLON

949

00337880632EXPA1

283.5

14:09:45

XLON

2,558

00337892579EXPA1

283.5

14:30:55

XLON

729

00337898263EXPA1

283.5

14:30:55

XLON

1,265

00337898265EXPA1

283.5

14:44:27

XLON

387

00337903662EXPA1

283.5

14:44:27

XLON

1,880

00337903663EXPA1

285.2

15:17:56

XLON

2,605

00337916874EXPA1

285.5

15:33:42

XLON

2,019

00337922585EXPA1

285.7

15:42:02

XLON

159

00337925048EXPA1

285.7

15:42:02

XLON

2,245

00337925049EXPA1

285.3

16:00:06

XLON

1,152

00337931522EXPA1

285.3

16:04:02

XLON

1,038

00337933200EXPA1

284.6

16:17:27

BATE

114

00337940278EXPA1

 

 

Contacts:

Tel:

Email:

Company Secretary

+44 (0) 77 6880 6248

secretariat@kingfisher.com

Investor Relations

+44 (0) 20 7644 1082

investorenquiries@kingfisher.com

Treasury

+44 (0) 20 7644 1170

treasury@kingfisher.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAKDDESFDEFA
Date   Source Headline
17th Jun 20207:00 amRNSFinal Results - (Part 1 of 2)
16th Jun 20202:52 pmRNSDirector/PDMR Shareholding
4th Jun 20205:00 pmRNS2019/20 Full Year Results Announcement Date
2nd Jun 20208:53 amRNSBlock listing Interim Review
1st Jun 202012:12 pmRNSTotal Voting Rights
18th May 20202:58 pmRNSDirector/PDMR Shareholding
13th May 20204:37 pmRNSHolding(s) in Company
12th May 20207:00 amRNSCompany Update
5th May 202010:54 amRNSTotal Voting Rights
27th Apr 20202:41 pmRNSDisclosure of Rights of Securities
22nd Apr 20203:18 pmRNSHolding(s) in Company
16th Apr 20203:06 pmRNSDirector/PDMR Shareholding
1st Apr 20202:49 pmRNSTotal Voting Rights
26th Mar 20209:28 amRNSDirector Declaration
23rd Mar 20207:00 amRNSFCA moratorium - preliminary financial statements
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 20208:57 amRNSDirector/PDMR Shareholding
16th Mar 20207:00 amRNSCOVID-19 update
2nd Mar 20204:00 pmRNSTotal Voting Rights
20th Feb 20202:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20209:48 amRNSTotal Voting Rights
22nd Jan 20202:44 pmRNSDirector/PDMR Shareholding
20th Jan 20202:00 pmRNSHolding(s) in Company
2nd Jan 202011:00 amRNSTotal Voting Rights
17th Dec 201911:18 amRNSDirector/PDMR Shareholding
12th Dec 20191:30 pmRNSHolding(s) in Company
9th Dec 201912:30 pmRNSHolding(s) in Company
2nd Dec 201910:02 amRNSTotal Voting Rights
27th Nov 20194:48 pmRNSDirectorate Change
26th Nov 20192:03 pmRNSDirector/PDMR Shareholding
22nd Nov 201911:00 amRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSQ3 Trading Update
12th Nov 20193:55 pmRNSDirector/PDMR Shareholding
12th Nov 20191:00 pmRNSHolding(s) in Company
6th Nov 20199:19 amRNSBlock listing Interim Review
4th Nov 20191:44 pmRNSDirector/PDMR Shareholding
1st Nov 20193:36 pmRNSTotal Voting Rights
23rd Oct 20195:20 pmRNSDirector/PDMR Shareholding
22nd Oct 20193:29 pmRNSDirector/PDMR Shareholding
21st Oct 201910:21 amRNSDirector Declaration
16th Oct 20191:00 pmRNSDirector/PDMR Shareholding
9th Oct 20197:00 amRNSDirectorate Change
4th Oct 20193:43 pmRNSHolding(s) in Company
1st Oct 20192:25 pmRNSDirector/PDMR Shareholding
1st Oct 201910:25 amRNSTotal Voting Rights
18th Sep 20195:11 pmRNSEMTN Programme
18th Sep 20197:00 amRNSHalf-Year Results - (Part 2 of 2)
18th Sep 20197:00 amRNSHalf-Year Results - (Part 1 of 2)
17th Sep 20192:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.